Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support

Drug and Alcohol Dependence

Volumn 180, Issue , 2017, Pages 52-55

  Kulesza, Magdalena ^a   Watkins, Katherine E ^a   Ober, Allison J ^a   Osilla, Karen C ^a   Ewing, Brett ^a  

^a RAND CORPORATION   (United States)

Author keywords

Alcohol; Internalized stigma; Opioids; Primary care treatment; Substance use problems

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OPIATE ADDICTION; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOCIAL BEHAVIOR; SOCIAL STIGMA; PRIMARY HEALTH CARE; PSYCHOLOGY;

ALCOHOLISM; COMORBIDITY; HUMANS; PRIMARY HEALTH CARE; RISK FACTORS; SOCIAL STIGMA; SUBSTANCE-RELATED DISORDERS;

EID: 85033436843     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2017.08.002     Document Type: Article

References (38)

1. Ali, B., Seitz-Brown, C.J., Daughters, S.B., The interacting effect of depressive symptoms, gender, and distress tolerance on substance use problems among residential treatment-seeking substance users. Drug Alcohol Depend. 1 (2015), 21–26.
2. Allensworth-Davies, D., Cheng, D.M., Smith, P.C., Samet, J.H., Saitz, R., The short inventory of problems-modified for drug use (SIP-DU): validity in a primary care sample. Am. J. Addict. 21 (2012), 257–262.
3. Bennett, M.E., Nidecker, M., Strong Kinnaman, J.E., Li, L., Bellack, A.S., Examination of the inventory of drug use consequences with individuals with serious and persistent mental illness and co-occurring substance use disorders. Am. J. Drug Alcohol Abuse 35 (2009), 386–390.
4. Blanchard, K.A., Morgenstern, J., Morgan, T.J., Lobouvie, E.W., Bux, D.A., Assessing consequences of substance use: psychometric properties of the inventory of drug use consequences. Psychol. Addict. Behav. 17 (2003), 328–331.
5. Corrigan, P., Watson, A., Barr, E., The self-stigma of mental illness: implications for self-esteem and self-efficacy. J. Soc. Clin. Psychol. 25 (2006), 875–884.
6. Corrigan, P.W., Larson, J.E., Rush, N., Self-stigma and the why try effect: impact on life goals and evidence-based practices. World Psychiatry 8 (2009), 75–81.
7. Corrigan, P., Schomerus, G., Shuman, V., Kraus, D., Perlick, D., Harnish, A., Kulesza, M., Kane-Willis, K., Qin, S., Smelson, D., Developing a research agenda for understanding the stigma of addictions, part I: lessons from the mental health stigma literature. Am. J. Addict. 26 (2017), 59–66.
8. Donovan, D.M., Bigelow, G.E., Brigham, G.S., Carroll, K.M., Cohen, A.J., Gardin, J.G., Hamilton, J.A., Husetis, M.A., Hughes, J.R., Lindblad, R., Marlatt, G.A., Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction 107 (2012), 694–708.
9. Earnshaw, V.A., Bogart, L.M., Dovidio, J.F., Williams, D.R., Stigma and racial/ethnic HIV disparities: moving forward. Am. Psychol. 68 (2013), 225–236.
10. Earnshaw, V.A., Smith, L.R., Cunningham, C.O., Copenhaver, M.M., Intersectionality of internalized HIV stigma and internalized substance use stigma: implications for depressive symptoms. J. Health Psychol. 20 (2015), 1083–1089.
11. Gorka, S.M., Ali, B., Daughters, S.B., The role of distress tolerance in the relationship between depressive symptoms and problematic alcohol use. Psychol. Addict. Behav. 26 (2012), 621–626.
12. Grant, B.F., Goldstein, R.B., Saha, T.B., Chou, P., Jung, J., Zhang, H., Pickering, R.P., Ruan, J., Smith, S.M., Huang, B., Hasin, D.S., Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiatry 72 (2015), 757–766.
13. Grant, B.F., Saha, T.B., Ruan, J., Goldstein, R.B., Chiu, P., Jung, J., Zhang, H., Smith, S., Pickering, R., Huang, B., Hasin, D.S., Epidemiology of DSM-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiatry 73 (2016), 39–47.
14. Haro, J.M., Arbabzadeh-Bouchez, S., Brugha, T.S., de Girolamo, G., Guyer, M.E., Jin, R., Lepine, J.P., Mazzi, F., Reneses, B., Vilagut, G., Sampson, N.A., Kessler, R.C., Concordance of the composite international diagnostic interview version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO world mental health surveys. Int. J. Methods Psychiatric Res. 15 (2006), 167–180.
15. Humeniuk, R., Ali, R., Babor, T.F., Farrell, M., Formigoni, M.L., Jittiwutikarn, J., de Lacerda, R.B., Ling, W., Marsden, J., Monteiro, M., Nhiwatiwa, S., Pal, H., Poznyak, V., Simon, S., Validation of the alcohol smoking and substance involvement screening test (ASSIST). Addiction 103 (2008), 1039–1047.
16. Kennedy-Hendricks, A., Busch, S.H., McGinty, E.E., Bachluber, M.A., Niederdepper, J., Gollust, S.E., Webster, D.W., Fiellin, D.A., Barry, C.A., Primary care physicians’ perspectives on the prescription opioid epidemic. Drug Alcohol Depend. 165 (2016), 61–70.
17. Kennedy-Hendricks, A., Barry, C.A., Gollust, S.E., Ensminger, M.E., Chisolm, M.S., McGinty, E.E., Social stigma toward persons with prescription opioid use disorder: associations with public support for punitive and public health-oriented policies. Psychiatric Serv. 68 (2017), 462–469.
18. Kiluk, B.D., Dreifuss, J.A., Weiss, R.D., Morgenstern, J., Carroll, K.M., The short inventory of problems – revised (SIP-R) psychometric properties within a large, diverse sample of substance use disorder treatment seekers. Psychol. Addict. Behav. 27 (2013), 307–314.
19. Kroenke, K., Spitzer, R.L., Williams, J.B., The patient health questionnaire-2: validity of a 2-item depression screener. Med. Care 41 (2003), 1284–1292.
20. Kroenke, K., Spitzer, R.L., Williams, J.B., Monahan, P.O., Lowe, B., Anxiety disorders in primary care prevalence, impairment, comorbidity, and detections. Ann. Intern. Med. 146 (2007), 317–325.
21. Kroenke, K., Spitzer, R.L., Williams, J.B., Lowe, B., An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 50 (2009), 613–621.
22. Kulesza, M., Larimer, M.E., Rao, D., Substance use related stigma: what we know and the way forward. J. Addict. Behav. Ther. Rehab. 2 (2013), 2–6.
23. Kulesza, M., Ramsey, S.E., Brown, R.A., Larimer, M.E., Stigma among individuals with substance use disorders: does it predict substance use, and does it diminish with treatment?. J. Addict. Behav. Ther. Rehabil., 3, 2014, 1000115.
24. Kulesza, M., Teachman, B.A., Werntz, A.J., Gasser, M.L., Lindgren, K.P., Correlates of public support toward federal funding for harm reduction strategies. Subst. Abuse. Treat. Prev. Policy, 10, 2015, 25.
25. Link, B.G., Phelan, J.C., Conceptualizing stigma. Annu. Rev. Sociol. 27 (2001), 363–385.
26. Lipari, R.N., Park-Lee, E., Van Horn, S., America's Need for and Receipt of Substance Use Treatment in 2015 The CBHSQ Report: September 29 2016., 2016, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, Rockville, MD.
27. Luoma, J.B., Kohlenberg, B.S., Hayes, S.C., Bunting, K., Rye, A.K., Reducing self-stigma is substance abuse through acceptance and commitment therapy model, manual development and pilot outcomes. Addict. Res. Theory 16 (2008), 149–165.
28. Luoma, J.B., Kohlenberg, B.S., Hayes, S.C., Fletcher, L., Slow and steady wins the race: a randomized clinical trial of acceptance and commitment therapy targeting shame in substance use disorders. J. Consult. Clin. Psychol. 80 (2012), 43–53.
29. Luoma, J.B., Rye, A., Kohlenberg, B.S., Hayes, S.C., A new measure of self-stigma in addiction: measure development and psychometrics. J. Psychopathol. Behav. Assess. 35 (2013), 223–234.
30. MacCoun, R.J., Moral outrage and opposition to harm reduction. Crim. Law Phil. 7 (2013), 83–98.
31. Miller, P.G., Miller, W.R., What should we be aiming for in the treatment of addiction?. Addiction 104 (2009), 685–686.
32. National Academies of Sciences, Engineering, and Medicine (NASEM), Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change. 2016, The National Academies Press, Washington, DC.
33. Ober, A.J., Watkins, K.W., Hunter, S.B., Lamp, K., Lind, M., Setodji, C.M., An organizational readiness intervention and randomized controlled trial to test strategies for implementing substance use disorder treatment into primary care: SUMMIT study protocol. Implement. Sci., 10, 2015, 66.
34. Pescosolido, B.A., Martin, J.K., Long, J.S., Medina, T.R., Phelan, J.C., Link, B.G., A disease like any other? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am. J. Psychiatry 167 (2010), 1321–1330.
35. Room, R., Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 24 (2005), 143–155.
36. Sheehan, D.V., The Anxiety Disease. 1986, Bantam New York, NY.
37. Smith, L.R., Earnshaw, V.A., Copenhaver, M.M., Cunningham, C.O., Substance use stigma: reliability and validity of a theory-based scale for substance using populations. Drug Alcohol Depend. 162 (2016), 34–43.
38. Sobell, L.C., Maisto, S.A., Sobell, M.B., Cooper, A.M., Reliability of alcohol abusers’ self-reports of drinking behavior. Behav. Res. Ther. 17 (1979), 157–160.